Cutler Group LLC / CA - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10.0%1,0000.0%0.00%
Q2 2023$10.0%1,0000.0%0.00%
Q1 2023$10.0%1,000
-16.7%
0.00%
Q4 2022$1
-99.9%
1,2000.0%0.00%
Q3 2022$1,000
-50.0%
1,2000.0%0.00%
Q2 2022$2,000
-33.3%
1,2000.0%0.00%
Q1 2022$3,000
-40.0%
1,2000.0%0.00%
Q4 2021$5,000
-16.7%
1,2000.0%0.00%
Q3 2021$6,000
-14.3%
1,2000.0%0.00%
Q2 2021$7,000
+133.3%
1,2000.0%0.00%
Q1 2021$3,0000.0%1,200
+140.0%
0.00%
Q4 2020$3,000
-70.0%
500
-76.2%
0.00%
Q3 2020$10,000
+150.0%
2,100
+40.0%
0.00%
Q2 2020$4,000
+100.0%
1,500
+400.0%
0.00%
Q1 2020$2,0000.0%3000.0%0.00%
Q4 2019$2,0000.0%3000.0%0.00%
Q3 2019$2,000
-33.3%
3000.0%0.00%
Q2 2019$3,000
-80.0%
300
-82.4%
0.00%
-100.0%
Q1 2019$15,000
-11.8%
1,7000.0%0.00%
+100.0%
Q4 2018$17,000
+142.9%
1,700
+54.5%
0.00%
Q3 2018$7,000
-41.7%
1,100
-90.4%
0.00%
Q2 2018$12,000
-58.6%
11,400
+0.9%
0.00%
-100.0%
Q1 2018$29,000
+163.6%
11,300
+769.2%
0.00%
Q4 2017$11,0001,3000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders